Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -0.3x - -0.3x | -0.3x |
| Selected Fwd P/E Multiple | -4.8x - -5.3x | -5.0x |
| Fair Value | €3.71 - €4.10 | €3.90 |
| Upside | 65.6% - 83.0% | 74.3% |
| Benchmarks | - | Full Ticker |
| Option Care Health, Inc. | - | NasdaqGS:OPCH |
| DocGo Inc. | - | NasdaqCM:DCGO |
| Addus HomeCare Corporation | - | NasdaqGS:ADUS |
| American Well Corporation | - | NYSE:AMWL |
| Integra LifeSciences Holdings Corporation | - | NasdaqGS:IART |
| ModivCare Inc. | - | DB:PRF0 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| OPCH | DCGO | ADUS | AMWL | IART | PRF0 | |||
| NasdaqGS:OPCH | NasdaqCM:DCGO | NasdaqGS:ADUS | NYSE:AMWL | NasdaqGS:IART | DB:PRF0 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | 23.3% | NM- | NM- | NM- | ||
| 3Y CAGR | 14.8% | -5.6% | 17.7% | NM- | NM- | NM- | ||
| Latest Twelve Months | 0.0% | -103.0% | 20.3% | 55.7% | -2217.0% | -2.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 3.7% | 1.6% | 5.3% | -120.1% | 5.5% | -2.0% | ||
| Prior Fiscal Year | 6.2% | 1.1% | 5.9% | -260.6% | 4.4% | -7.4% | ||
| Latest Fiscal Year | 4.2% | 3.2% | 6.4% | -81.8% | -0.4% | -7.2% | ||
| Latest Twelve Months | 3.9% | -0.1% | 6.5% | -59.1% | -30.9% | -8.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 14.0x | 7.5x | 14.9x | 0.7x | 9.0x | 11.6x | ||
| Price / LTM Sales | 0.9x | 0.3x | 1.6x | 0.4x | 0.6x | 0.0x | ||
| LTM P/E Ratio | 21.7x | -216.6x | 24.6x | -0.7x | -2.0x | -0.2x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -216.6x | -0.7x | 24.6x | |||||
| Historical LTM P/E Ratio | -22.5x | -0.9x | 90.2x | |||||
| Selected P/E Multiple | -0.3x | -0.3x | -0.3x | |||||
| (x) LTM Net Income | (229) | (229) | (229) | |||||
| (=) Equity Value | 64 | 67 | 71 | |||||
| (/) Shares Outstanding | 14.4 | 14.4 | 14.4 | |||||
| Implied Value Range | 4.46 | 4.70 | 4.93 | |||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | ||||
| Implied Value Range (Trading Cur) | 3.86 | 4.06 | 4.26 | 2.24 | ||||
| Upside / (Downside) | 72.2% | 81.3% | 90.3% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | OPCH | DCGO | ADUS | AMWL | IART | PRF0 | |
| Value of Common Equity | 4,586 | 139 | 1,942 | 111 | 979 | 37 | |
| (/) Shares Outstanding | 162.3 | 99.1 | 18.2 | 15.8 | 77.9 | 14.4 | |
| Implied Stock Price | 28.26 | 1.40 | 106.96 | 7.04 | 12.56 | 2.59 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.16 | |
| Implied Stock Price (Trading Cur) | 28.26 | 1.40 | 106.96 | 7.04 | 12.56 | 2.24 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.16 | |